Jun 17, 2026 07:00AM
Apr 17, 2026 02:00PM
Apr 17, 2026 02:00PM
Apr 15, 2026 07:00AM
Mar 24, 2026 02:46PM
Dec 8, 2025 07:00AM
Dec 8, 2025 07:00AM UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM
Oct 29, 2025 07:00AM
Sep 17, 2025 07:00AM
Jun 12, 2025 12:30PM
May 19, 2025 12:30PM UCB and Domino Data Lab Collaborate to Modernize Statistical Computing Environment in Life Sciences
Apr 3, 2025 07:00AM
Mar 19, 2025 07:00AM
Mar 12, 2025 01:54PM
Mar 7, 2025 08:00AM
Feb 27, 2025 07:00AM
Jan 16, 2025 07:00AM
Dec 6, 2024 12:00PM UCB Presents New Data on Impact and Burden of Epilepsy at 2024 American Epilepsy Society (AES) Annual Meeting
Nov 26, 2024 07:00AM
Nov 20, 2024 07:00AM
Nov 14, 2024 12:46PM
Sep 23, 2024 07:00AM
Aug 16, 2024 05:36AM
Jun 24, 2024 07:00AM
Jun 20, 2024 08:00AM UCB Launches Dravet Syndrome Sound of Profound Moments: Family Video Project
May 23, 2024 07:00AM
Apr 12, 2024 07:00AM
Apr 4, 2024 07:00AM
Feb 28, 2024 07:03AM
Jan 3, 2024 07:00AM
Dec 8, 2023 02:30PM
Dec 2, 2023 07:00AM UCB presents new data about the real-world experience of FINTEPLA® (fenfluramine) and rare epilepsy syndromes at 2023 American Epilepsy Society (AES) Annual Meeting
Dec 1, 2023 07:00AM
Nov 14, 2023 07:00AM
Nov 1, 2023 07:00AM
Oct 31, 2023 07:00AM
Oct 18, 2023 07:00AM
Oct 17, 2023 06:34PM
Oct 13, 2023 12:00PM UCB Reinforces Commitment to Advancing Care in Hidradenitis Suppurativa with Six Abstracts at SHSA 2023
Oct 12, 2023 12:20PM
Oct 4, 2023 01:06PM
Jul 21, 2023 07:00AM
Jun 27, 2023 07:00AM
Apr 20, 2023 07:00AM
Apr 17, 2023 07:14AM
Mar 18, 2023 02:10PM Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful, Deep and Maintained Response over 48 Weeks
Mar 16, 2023 07:00AM

323,577 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All